Press Releases

Kevin Bell CO-Founder & CEO of Kali Partners/VP of Tyson 2.0 joins THC Therapeutics
Over the course of his [Bell's] career, he has owned, operated, and exited more than a dozen successful businesses and introduced industry-changing ideas to emerging markets both domestically and internationally.
Overview
Disclosures
THC Therapeutics is an audited, SEC reporting company. Visit our disclosures page to browse through our filings.
Contact IR
For detailed investor inquiries you can reach out to our Investor Relations firm via email or phone.
FAQs
Public companies can be daunting to newcomers, read through our investors most commonly asked questions.
Coming soon